Protagenic Therapeutics, Inc.\new Current Assets
Protagenic Therapeutics, Inc.\new (PTIX) had Current Assets of $709.87 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-19
- 2026-06-30: Assets, Current $709.87K.
- 2026-03-31: Assets, Current $1.54M.
- 2025-12-31: Assets, Current $2.30M.
- 2025-09-30: Assets, Current $2.86M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $709.87K 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $1.54M 10-Q · filed 2026-08-19 | |
| 2025-12-31 | $2.30M 10-Q · filed 2026-03-09 | |
| 2025-09-30 | $2.86M 10-Q · filed 2025-11-26 | |
| 2025-06-30 | $4.33M 10-QT · filed 2025-09-10 | |
| 2025-03-31 | $89.09K 10-K · filed 2026-08-14 | $928.18K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.88M 10-Q · filed 2025-05-13 | |
| 2024-09-30 | $1.42M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.37M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.47M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $4.20M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $5.38M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $6.92M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $7.66M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $8.04M 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | $8.25M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $9.01M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $9.80M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $11.06M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $11.66M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $12.06M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $196.14K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $879.25K 10-K · filed 2022-04-07 | |
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.19M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $785.66K 10-Q · filed 2020-06-18 | |
| 2019-12-31 | $841.98K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $286.92K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $349.31K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $464.24K 10-Q · filed 2019-05-16 | |
| 2018-12-31 | $696.27K 10-K · filed 2020-04-29 | |
| 2018-09-30 | $989.72K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.09M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.47M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.78M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $2.22M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $2.45M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $2.77M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $3.16M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $3.59M 10-Q · filed 2016-11-17 | |
| 2016-06-30 | $3.79M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $3.75M 10-Q · filed 2016-07-25 | |
| 2015-12-31 | $3.34K 10-K/A · filed 2017-05-08 | $25.00K 10-Q · filed 2016-03-11 |
| 2015-09-30 | $59.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $132.00K 10-Q · filed 2016-03-11 | |
| 2015-03-31 | $146.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $22.73K 8-K/A · filed 2016-07-12 | $260.00K 10-Q · filed 2015-02-06 |
| 2014-09-30 | $245.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $245.00K 10-K · filed 2015-09-25 | |
| 2011-09-30 | $9.06M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $8.58M 10-Q/A · filed 2011-09-07 | |
| 2010-12-31 | $12.31M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |